We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SGMT market cap is 167.17M. The company's latest EPS is USD -0.9088 and P/E is -5.90.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 2M | 0 | 0 | 0 | 0 |
| Operating Income | -7.45M | -9.47M | -8.77M | -10.59M | -16.9M |
| Net Income | -6.35M | -8.15M | -6.63M | -8.12M | -14.62M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 2M |
| Operating Income | -23.72M | -31.06M | -30.74M |
| Net Income | -24.44M | -30.5M | -27.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 102.93M | 96.72M | 194.53M | 189.02M | 174.78M |
| Total Liabilities | 5.05M | 5.65M | 4.51M | 5.73M | 4.09M |
| Total Equity | 97.88M | 91.07M | 190.02M | 183.29M | 170.68M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.03M | 33.03M | 96.72M |
| Total Liabilities | 2.67M | 5.36M | 5.65M |
| Total Equity | -158.26M | -186.95M | 91.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -16.68M | -23.77M | -6.21M | -11.84M | -31.41M |
| Investing | 32.2M | 12.58M | 3M | -72.16M | -71.53M |
| Financing | 86.17M | 86.17M | 104.85M | 104.82M | 104.82M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.71M | -24.49M | -23.77M |
| Investing | N/A | -32.01M | 12.58M |
| Financing | 9.74M | -73k | 86.17M |
| Market Cap | 167.17M |
| Price to Earnings Ratio | -5.90 |
| Price to Sales Ratio | 82.21 |
| Price to Cash Ratio | 2.19 |
| Price to Book Ratio | 1.81 |
| Dividend Yield | - |
| Shares Outstanding | 30.67M |
| Average Volume (1 week) | 2.77M |
| Average Volume (1 Month) | 1.22M |
| 52 Week Change | 14.73% |
| 52 Week High | 20.71 |
| 52 Week Low | 2.39 |
| Spread (Intraday) | 0.13 (2.39%) |
| Company Name | Sagiment Biosciences Inc |
| Address |
2140 south dupont highway camden, delaware 19934 |
| Website | https://www.sagimet.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
